Therefore, this current study verifies that PDGF-BB plays a critical role in CD11b+Gr-1+ MDSC-mediated breast cell retention in the lungs and, if targeted, may have potential therapeutic benefit to reduce lung metastasis of breast cancer. This evidence concerns the gene ITGAM and breast carcinoma.